Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma

BACKGROUND: The polymorphisms of the cyclin‐dependent kinase inhibitor (CDKN1A) gene and matrix metalloproteinase‐9 (MMP9) gene may increase one's susceptibility to malignancies. In this study, the association of the single nucleotide polymorphisms (SNPs) CDKN1A rs1059234 c.70C>T at the 3′ u...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltayeb, Majdolin Mohammed, Ali, Mohamed M., Omar, Saeed M., Mohamed, Nouh Saad, Adam, Ishag, Hamdan, Hamdan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747550/
https://www.ncbi.nlm.nih.gov/pubmed/36259348
http://dx.doi.org/10.1002/mgg3.2074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747550/
https://www.ncbi.nlm.nih.gov/pubmed/36259348
http://dx.doi.org/10.1002/mgg3.2074

Ejemplares similares